LBT Innovations

LBT Innovations Limited is a medical technology company based in Adelaide, Australia, focused on developing and commercializing innovative solutions for the healthcare and laboratory supply markets. The company offers advanced products such as MicroStreak, an automated culture-plate streaking system, and the Automated Plate Assessment System (APAS), which utilizes artificial intelligence and machine learning for the automated imaging, analysis, and interpretation of microbiology culture plates. APAS is notable for being the only FDA-cleared instrument of its kind globally. Additionally, LBT Innovations has developed WoundVue, an AI-driven technology that aids clinicians in assessing and managing chronic wounds. Founded in 2004, the company has achieved regulatory clearances including US FDA, CE Mark, and TGA, enabling its products to be marketed in the United States, European Union, and Australia, with early sales reflecting its clinical effectiveness validated through extensive trials.